HBC Hofseth Biocare

Hofseth BioCare ASA: Disclosures of Large Shareholdings

Hofseth BioCare ASA: Disclosures of Large Shareholdings

Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company.

The following shareholders of the Company have, on 27 October 2025, been allocated new shares in the Private Placement which implies that their holdings have surpassed a notifiable threshold:

  • Guy Urquhart have subscribed for 55,444,444 new shares in the Private Placement. Following this, Guy Urquhart holds 55,444,444 shares in the Company, corresponding to 12.21% of the shares in the Company and 12.21% of the votes at the Company's general meetings.

The following shareholders have had their holdings diluted as a consequence of the Private Placement and thereby surpassed a notifiable threshold:

  • Following completion of tranche 1 in the Private Placement, funds managed by Bonafide Wealth Management holds 66,023,125 shares in the Company, corresponding to 14.54% of the ordinary shares in the Company and 14.54% of the votes at the Company's general meetings.
  • Following completion of tranche 1 in the Private Placement, Aqua-Spark holds 22,433,338 shares in the Company, corresponding to 4.94% of the ordinary shares in the Company and 4.94% of the votes at the Company's general meetings.
  • Following completion of tranche 1 in the Private Placement, Yokorei Co. Ltd. holds 40 951 333 shares in the Company, corresponding to 9.02% of the ordinary shares in the Company and 9.02% of the votes at the Company's general meetings.

This disclosure is made pursuant to section 4-2 of the Norwegian Securities Trading Act and is subject to the disclosure requirement pursuant to section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Jon Olav Ødegård, CEO at HBC

Phone:

E-mail:



EN
27/10/2025

Underlying

HBCHofseth Biocare

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hofseth Biocare

 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Mandatory Notification of Trade

Hofseth BioCare ASA: Mandatory Notification of Trade Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company. In the Private Placement, Hofseth International AS was allocated 28,666,666 new shares at the subscription price of NOK 1.80. Please refer to the attached notification form for further information. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19. For furth...

October 27, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Ex. Subsequent Offering Today

Ex. Subsequent Offering Today NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 relating to a contemplated subsequent offering of up to 16,666,666 new shares directed towards certain eligible shareholders...

October 27, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Key Information Relating to Subsequent Offering

Hofseth BioCare ASA: Key Information Relating to Subsequent Offering NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares i...

October 27, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Disclosures of Large Shareholdings

Hofseth BioCare ASA: Disclosures of Large Shareholdings Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company. The following shareholders of the Company have, on 27 October 2025, been allocated new shares in the Private Placement which implies that their holdings have surpassed a notifiable threshold: Guy Urquhart have subscribed for 55,444,444 new shares in the Private Placement. Following this, Guy Urquhart holds 55,444,444...

October 27, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Private placement successfully placed

Hofseth BioCare ASA: Private placement successfully placed NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement from Hofseth BioCare ASA ("HBC" or the "Company") published on 24 October 2025 regarding a private placement (the "Private Placement") of between 86,096,132 and 1...

October 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch